Closed continuous hyperthermic peritoneal perfusion model in mice with peritoneal dissemination of colon 26

An original model of closed continuous hyperthermic peritoneal perfusion (CHPP) in mice is presented and was found to support the efficacy of intraperitoneal hyperthermia. Closed CHPP was performed after intraperitoneal inoculation of transplantable colon 26 cells into a mouse. Colon 26 cells (5 × 104) were injected into 18 mice. The mice were then allocated to six groups of three each and subjected to peritoneal perfusion over time. Peritoneal washings from each mouse were sampled and counted by the cytosmear method. On day 10 after inoculation, colonies of the disseminated tumour were seen on the mesentery by staining with 0.1% methylene blue for 5 min. The number of tumour nodules on the mesentery was counted. The number of washed-out tumour cells decreased the most at 24 h after inoculation, and 76% of the inoculated cells did not wash out during the peritoneal perfusion procedure. CHPP was performed after 24 h when colon 26 cells were injected into the peritoneal cavity because this status may represent micrometastasis. The total number of nodules on the mesentery in the CHPP group was significantly smaller than that in the control (p<0.02). In conclusion, because this treatment model is similar to the clinical CHPP, the biostaining model might be useful for the evaluation of peritoneal dissemination and it was unique and valuable in demonstrating an effective treatment for the prevention of peritoneal dissemination.

[1]  H. Kuwano,et al.  Increased thermosensitivity of mouse colorectal carcinoma cells transfected with human FUT1 gene. , 2002, Cancer letters.

[2]  H. Ishikawa,et al.  Intrathoracic Thermochemotherapy for the Treatment of Post-operative Malignant Pleural Effusion in Primary Lung Carcinoma-Report of a Case , 2001 .

[3]  H. Kitagawa,et al.  Subtotal peritonectomy with chemohyperthermic peritoneal perfusion for peritonitis carcinomatosa in gastrointestinal cancer. , 2000, Oncology reports.

[4]  S. Takenoshita,et al.  Eradication of peritoneal dissemination in mice by combination therapy using liposome-encapsulated leucovorin with 5-fluorouracil , 1997 .

[5]  C. Ollayos.  Update on the Papanicolaou smear: new issues for the 1990s. , 1997, Military medicine.

[6]  S. Takenoshita,et al.  A novel ex vivo method for assaying adhesion of cancer cells to the peritoneum. , 1994, Cancer letters.

[7]  Y. Maehara,et al.  Continuous hyperthermic peritoneal perfusion with cisplatin in mice with peritoneal dissemination of B16 melanoma. , 1994, Seminars in surgical oncology.

[8]  Y. Nagamachi,et al.  Carcinoembryonic antigen levels in peritoneal washings can predict peritoneal recurrence after curative resection of gastric cancer , 1991, Cancer.

[9]  K. Kobayashi,et al.  Positive results of combined therapy of surgery and intraperitoneal hyperthermic perfusion for far-advanced gastric cancer. , 1990, Annals of surgery.

[10]  J. Doroshow,et al.  Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  R. Hamazoe,et al.  Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C , 1988, Cancer.

[12]  Y. Osaki,et al.  Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug. , 1984, Cancer research.

[13]  D L Morton,et al.  Clinical thermochemotherapy a controlled trial in advanced cancer patients , 1984, Cancer.

[14]  J. Fortner,et al.  Intraperitoneal hyperthermic treatment of implanted peritoneal cancer in rats. , 1980, Cancer research.

[15]  H. Kuwano,et al.  A new method for assaying adhesion of cancer cells to the greater omentum and its application for evaluating anti-adhesion activities of chemically synthesized oligosaccharides , 2004, Clinical & Experimental Metastasis.

[16]  I. Hyodo,et al.  Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  S. Fushida,et al.  Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second‐look operation , 1990, Cancer.

[18]  V. Vicente,et al.  Thermochemotherapy for B16 melanoma: combination therapy of hyperthermia, melphalan, and CCNU in mice. , 1990, Pigment cell research.